Company: ANTX
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0000950170-25-052852
Chunk: 2

Company: AN2 Therapeutics, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 2
---
-Approval and Permissible Non-Audit Services of Independent Registered Public Accounting Firm       |     |      |
| Recommendation of our Board                                                                                                      |     |      |
| AUDIT COMMITTEE REPORT                                                                                                           |     |   30 |
| TRANSACTION OF OTHER BUSINESS                                                                                                    |     |   31 |
| REQUIREMENTS, INCLUDING DEADLINES, FOR SUBMISSION OF PROXY PROPOSALS, NOMINATION OF DIRECTORS AND OTHER BUSINESS OF STOCKHOLDERS |     |   31 |
| HOUSEHOLDING OF ANNUAL MEETING MATERIALS                                                                                         |     |   31 |
| DELINQUENT SECTION 16(A) REPORTS                                                                                                 |     |   32 |
| OTHER MATTERS                                                                                                                    |     |   32 |
| Fiscal Year 2024 Annual Report and SEC Filings                                                                                   |     |      |

<div align='center'>iii

AN2 Therapeutics, Inc.

1800 El Camino Real, Suite D

Menlo Park, California 94027

PROXY STATEMENT QUESTIONS AND ANSWERS</div>

Why am I receiving these proxy materials?

The Board of Directors (the “Board”) of AN2 Therapeutics, Inc., a Delaware corporation (“AN2 Therapeutics,” the “Company,” “we,” “us,” or “our”), has made these proxy materials available to you on the internet or, upon your request, by delivering printed versions of these materials to you by mail, in connection with the solicitation of proxies for use at our 2025 Annual Meeting of Stockholders (the “Annual Meeting”). The Board is soliciting your proxy to vote at the Annual Meeting, including at any adjournments or postponements of the meeting. You are invited to attend the Annual Meeting in person to vote on the proposals described in this proxy statement (the “Proxy Statement”). However, you do not need to attend the meeting to vote your shares. Instead, you may simply complete, sign and return the enclosed proxy card or voting instruction form, or follow the instructions below to submit your proxy over the telephone or through the internet.

Why did I receive a one-page notice in the mail regarding the internet availability of proxy materials instead of a full set of printed proxy materials?

Pursuant to the “notice and access” rules adopted by the SEC, we have elected to provide stockholders access to our proxy materials over the internet. Accordingly, on or about April 10, 2025, we will mail a Notice of Internet Availability of Proxy Materials